Infectious Diseases

Mobilizing this country’s pharmacists is essential to help protect vulnerable patients from syncytial virus (RSV) this season.

Methods to improve protection among individuals 65 + against influenza have included newer vaccines technologies developed to directly address the changes in immune function. Pharmacists should be knowledgeable about different types of vaccines to assist patients in making informed decisions.

Here are some reasons why the conclusions of this Cochrane Review are misleading.

Recorded webinar on current issues in outpatient treatment of COVID-19 for pharmacists available from the Canadian Pharmacists Association.

The update outlines the specific populations who would most benefit from a third or booster shot.

With schools reopening soon, Canadian parents are worried infections among children will soar.

The Germany-based company, which developed the first widely approved coronavirus shot together with U.S. partner Pfizer, aims to begin clinical trials for a "safe and highly effective malaria vaccine'' by the end of 2022.

For those in the medical sphere who've yet to have the chance to give a COVID-19 vaccine, this video by the Leslie Dan Faculty of Pharmacy at the University of Toronto provides a virtual demonstration on preparing the Pfizer-BioNTech vaccine.

Ottawa–A vaccine study in the United Kingdom reports that getting a dose of the Pfizer-BioNTech vaccine four weeks after a dose of Oxford-AstraZeneca produced a much stronger immune response than two doses of AstraZeneca.